Successful Intraosseous (IO) Adenosine Administration for the Termination of Supraventricular Tachycardia (SVT) in a 3.5-Year-Old Child—Case Report and Literature Review
Open Access
- 30 July 2024
- journal article
- case report
- Published by MDPI AG in Healthcare
- Vol. 12 (15) , 1509
Abstract
Paediatric supraventricular tachycardia (SVT) is a common arrhythmia of great clinical significance. If not treated promptly, it can cause heart failure and cardiogenic shock. Depending on the patient’s condition, SVT treatment involves vagal manoeuvres, pharmacological, or direct current cardioversion. The goal of acute SVT management is to immediately convert SVT to a normal sinus rhythm (NSR) and prevent its recurrence. Adenosine is recommended as the first-line treatment for stable SVT by the European Resuscitation Council (ERC) and American Heart Association (AHA) guidelines, when vagal manoeuvres have proven ineffective. The ERC and AHA guidelines recommend the intravenous route of administration. The intraosseous (IO) administration technique is also possible, but still relatively unknown. The aim of this paper is to describe a 3.5-year-old child with SVT that was converted to NSR following IO administration of adenosine. Successful conversion was achieved after the second attempt with the adenosine dose. In the described case, there was no recurrence of SVT.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- The Single-Syringe Versus the Double-Syringe Techniques of Adenosine Administration for Supraventricular Tachycardia: A Systematic Review and Meta-AnalysisAmerican Journal of Cardiovascular Drugs, 2023
- Comparison between the double‐syringe and the single‐syringe techniques of adenosine administration for terminating supraventricular tachycardia: A pilot, randomized controlled trialClinical Cardiology, 2022
- European Resuscitation Council Guidelines 2021: Paediatric Life SupportResuscitation, 2021
- Management of Supraventricular Tachycardia in InfantsPediatric Drugs, 2017
- A Novel Method of Intraosseous Infusion of Adenosine for the Treatment of Supraventricular Tachycardia in an InfantPediatric Emergency Care, 2017
- Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statementEP Europace, 2013
- Selective adenosine agonists and myocardial perfusion imagingJournal of Nuclear Cardiology, 2012
- Supraventricular Tachycardia in the Pediatric Primary Care Setting: Age-related Presentation, Diagnosis, and ManagementJournal of Pediatric Health Care, 2008
- Intraosseous AdenosineArchives of Pediatrics & Adolescent Medicine, 1994
- Supraventricular tachycardia mechanisms and their age distribution in pediatric patientsThe American Journal of Cardiology, 1992